Bisphenol a Interacts with Gper, Activates EGFR and ERK Signaling and Antagonizes Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Breast Cancer Cells
Publication
, Journal Article
Sauer, SJ; Davis, JB; Lyerly, HK; Shah, I; Williams, KP; Devi, GR
Published in: ENDOCRINE REVIEWS
June 1, 2014
Duke Scholars
Published In
ENDOCRINE REVIEWS
EISSN
1945-7189
ISSN
0163-769X
Publication Date
June 1, 2014
Volume
35
Issue
3
Publisher
ENDOCRINE SOC
Related Subject Headings
- Endocrinology & Metabolism
- 3215 Reproductive medicine
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sauer, S. J., Davis, J. B., Lyerly, H. K., Shah, I., Williams, K. P., & Devi, G. R. (2014). Bisphenol a Interacts with Gper, Activates EGFR and ERK Signaling and Antagonizes Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Breast Cancer Cells. ENDOCRINE REVIEWS, 35(3).
Sauer, Scott Jeffrey, John B. Davis, H Kim Lyerly, Imran Shah, Kevin P. Williams, and Gayathri R. Devi. “Bisphenol a Interacts with Gper, Activates EGFR and ERK Signaling and Antagonizes Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Breast Cancer Cells.” ENDOCRINE REVIEWS 35, no. 3 (June 1, 2014).
Sauer SJ, Davis JB, Lyerly HK, Shah I, Williams KP, Devi GR. Bisphenol a Interacts with Gper, Activates EGFR and ERK Signaling and Antagonizes Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Breast Cancer Cells. ENDOCRINE REVIEWS. 2014 Jun 1;35(3).
Sauer, Scott Jeffrey, et al. “Bisphenol a Interacts with Gper, Activates EGFR and ERK Signaling and Antagonizes Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Breast Cancer Cells.” ENDOCRINE REVIEWS, vol. 35, no. 3, ENDOCRINE SOC, June 2014.
Sauer SJ, Davis JB, Lyerly HK, Shah I, Williams KP, Devi GR. Bisphenol a Interacts with Gper, Activates EGFR and ERK Signaling and Antagonizes Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Breast Cancer Cells. ENDOCRINE REVIEWS. ENDOCRINE SOC; 2014 Jun 1;35(3).
Published In
ENDOCRINE REVIEWS
EISSN
1945-7189
ISSN
0163-769X
Publication Date
June 1, 2014
Volume
35
Issue
3
Publisher
ENDOCRINE SOC
Related Subject Headings
- Endocrinology & Metabolism
- 3215 Reproductive medicine
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 0601 Biochemistry and Cell Biology